Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
Abstract: The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.
Type:
Grant
Filed:
October 8, 2019
Date of Patent:
March 2, 2021
Assignee:
Altum Pharmaceuticals Inc.
Inventors:
Rickey Roy Rhinebarger, Gina G. Stetsko
Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
Abstract: The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.
Type:
Grant
Filed:
February 9, 2018
Date of Patent:
February 4, 2020
Assignee:
Altum Pharmaceuticals Inc.
Inventors:
Rickey Roy Rhinebarger, Gina G. Stetsko
Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.